Hearing Loss in Multi-Drug Resistant Tuberculosis Patients Treated with Aminoglycosides
Author Information
Author(s): Duggal Prahlad, Sarkar Malay
Primary Institution: Dr. Rajinder Prasad Govt. Medical College, Tanda, Kangra, Himachal Pradesh, India
Hypothesis
The study investigates the impact of second line aminoglycoside anti-tubercular drugs on the hearing status of MDR-TB patients.
Conclusion
Aminoglycosides used in MDR-TB patients may result in irreversible hearing loss involving higher frequencies.
Supporting Evidence
- 18.75% of patients developed sensorineural hearing loss involving higher frequencies.
- 6.25% had involvement of speech frequencies.
- All hearing losses were permanent with no threshold improvement after aminoglycoside discontinuation.
Takeaway
Some medicines for tuberculosis can hurt your hearing, and once that happens, it can't be fixed.
Methodology
The study included 64 patients treated with second line aminoglycosides, with audiometric evaluations performed before, during, and after treatment.
Limitations
The study did not measure serum aminoglycoside levels due to cost constraints.
Participant Demographics
Patients aged 17 to 65 years, with 60.9% male and 39.1% female, mostly from rural backgrounds and low socio-economic status.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website